nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—SLC29A1—Fluorouracil—colon cancer	0.631	1	CbGbCtD
Fludarabine—SLC28A3—digestive system—colon cancer	0.00458	0.0706	CbGeAlD
Fludarabine—SLC28A3—bone marrow—colon cancer	0.00422	0.0651	CbGeAlD
Fludarabine—DCK—Topotecan—Irinotecan—colon cancer	0.00408	0.571	CbGdCrCtD
Fludarabine—RRM1—smooth muscle tissue—colon cancer	0.00324	0.0499	CbGeAlD
Fludarabine—DCK—embryo—colon cancer	0.0032	0.0493	CbGeAlD
Fludarabine—RRM1—renal system—colon cancer	0.00311	0.048	CbGeAlD
Fludarabine—POLA1—Vinblastine—Vincristine—colon cancer	0.00307	0.429	CbGdCrCtD
Fludarabine—POLA1—bone marrow—colon cancer	0.00297	0.0457	CbGeAlD
Fludarabine—POLA1—vagina—colon cancer	0.00284	0.0438	CbGeAlD
Fludarabine—RRM1—lymphoid tissue—colon cancer	0.00259	0.0399	CbGeAlD
Fludarabine—RRM1—digestive system—colon cancer	0.00255	0.0394	CbGeAlD
Fludarabine—SLC29A1—renal system—colon cancer	0.00253	0.039	CbGeAlD
Fludarabine—POLA1—liver—colon cancer	0.0024	0.0369	CbGeAlD
Fludarabine—RRM1—bone marrow—colon cancer	0.00236	0.0363	CbGeAlD
Fludarabine—RRM1—Fluoropyrimidine Activity—TYMS—colon cancer	0.00228	0.0417	CbGpPWpGaD
Fludarabine—DCK—Pyrimidine metabolism—TYMS—colon cancer	0.00226	0.0414	CbGpPWpGaD
Fludarabine—RRM1—vagina—colon cancer	0.00226	0.0348	CbGeAlD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—MSH6—colon cancer	0.0022	0.0403	CbGpPWpGaD
Fludarabine—POLA1—G1/S-Specific Transcription—TYMS—colon cancer	0.00218	0.04	CbGpPWpGaD
Fludarabine—SLC29A1—lymphoid tissue—colon cancer	0.0021	0.0324	CbGeAlD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—TYMS—colon cancer	0.00208	0.0382	CbGpPWpGaD
Fludarabine—SLC29A1—digestive system—colon cancer	0.00208	0.032	CbGeAlD
Fludarabine—DCK—lymphoid tissue—colon cancer	0.00201	0.031	CbGeAlD
Fludarabine—DCK—digestive system—colon cancer	0.00198	0.0306	CbGeAlD
Fludarabine—SLC29A1—bone marrow—colon cancer	0.00192	0.0295	CbGeAlD
Fludarabine—RRM1—liver—colon cancer	0.0019	0.0293	CbGeAlD
Fludarabine—Adenosine triphosphate—AKT1—colon cancer	0.00187	0.463	CrCbGaD
Fludarabine—Adenosine monophosphate—SRC—colon cancer	0.00185	0.456	CrCbGaD
Fludarabine—POLA1—lymph node—colon cancer	0.00184	0.0283	CbGeAlD
Fludarabine—SLC29A1—vagina—colon cancer	0.00183	0.0283	CbGeAlD
Fludarabine—DCK—bone marrow—colon cancer	0.00183	0.0282	CbGeAlD
Fludarabine—DCK—vagina—colon cancer	0.00175	0.027	CbGeAlD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—MSH6—colon cancer	0.00169	0.031	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.00159	0.0291	CbGpPWpGaD
Fludarabine—SLC29A1—liver—colon cancer	0.00155	0.0238	CbGeAlD
Fludarabine—DCK—liver—colon cancer	0.00148	0.0228	CbGeAlD
Fludarabine—RRM1—lymph node—colon cancer	0.00146	0.0225	CbGeAlD
Fludarabine—POLA1—E2F mediated regulation of DNA replication—TYMS—colon cancer	0.00128	0.0235	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—MSH6—colon cancer	0.00124	0.0227	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—TYMS—colon cancer	0.00121	0.0221	CbGpPWpGaD
Fludarabine—SLC29A1—lymph node—colon cancer	0.00119	0.0183	CbGeAlD
Fludarabine—RRM1—Nucleotide metabolism—TYMS—colon cancer	0.00114	0.021	CbGpPWpGaD
Fludarabine—DCK—lymph node—colon cancer	0.00113	0.0175	CbGeAlD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.00108	0.0199	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—TYMS—colon cancer	0.00105	0.0192	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000912	0.0167	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.000895	0.0164	CbGpPWpGaD
Fludarabine—DCK—Nucleotide metabolism—TYMS—colon cancer	0.000881	0.0161	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—TYMS—colon cancer	0.000807	0.0148	CbGpPWpGaD
Fludarabine—RRM1—Fluoropyrimidine Activity—TP53—colon cancer	0.000755	0.0138	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.000729	0.0134	CbGpPWpGaD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—TP53—colon cancer	0.000691	0.0127	CbGpPWpGaD
Fludarabine—Upper respiratory tract infection—Fluorouracil—colon cancer	0.00068	0.00285	CcSEcCtD
Fludarabine—POLA1—E2F transcription factor network—TYMS—colon cancer	0.00068	0.0125	CbGpPWpGaD
Fludarabine—Acute coronary syndrome—Irinotecan—colon cancer	0.000671	0.00281	CcSEcCtD
Fludarabine—Renal failure—Irinotecan—colon cancer	0.00067	0.00281	CcSEcCtD
Fludarabine—Myocardial infarction—Irinotecan—colon cancer	0.000668	0.0028	CcSEcCtD
Fludarabine—Stomatitis—Irinotecan—colon cancer	0.000664	0.00278	CcSEcCtD
Fludarabine—Deafness—Capecitabine—colon cancer	0.000661	0.00277	CcSEcCtD
Fludarabine—RRM1—Metabolism—CA7—colon cancer	0.000661	0.0121	CbGpPWpGaD
Fludarabine—Hepatic failure—Capecitabine—colon cancer	0.000658	0.00276	CcSEcCtD
Fludarabine—Pneumonia—Fluorouracil—colon cancer	0.000656	0.00275	CcSEcCtD
Fludarabine—Hyperuricaemia—Methotrexate—colon cancer	0.000654	0.00274	CcSEcCtD
Fludarabine—Acute coronary syndrome—Fluorouracil—colon cancer	0.000643	0.00269	CcSEcCtD
Fludarabine—Myocardial infarction—Fluorouracil—colon cancer	0.000639	0.00268	CcSEcCtD
Fludarabine—Neuropathy peripheral—Fluorouracil—colon cancer	0.000639	0.00268	CcSEcCtD
Fludarabine—Stomatitis—Fluorouracil—colon cancer	0.000636	0.00266	CcSEcCtD
Fludarabine—Urinary tract infection—Fluorouracil—colon cancer	0.000634	0.00266	CcSEcCtD
Fludarabine—Hypoaesthesia—Vincristine—colon cancer	0.000625	0.00262	CcSEcCtD
Fludarabine—Respiratory failure—Methotrexate—colon cancer	0.000618	0.00259	CcSEcCtD
Fludarabine—Blood uric acid increased—Methotrexate—colon cancer	0.000618	0.00259	CcSEcCtD
Fludarabine—Epistaxis—Fluorouracil—colon cancer	0.000615	0.00258	CcSEcCtD
Fludarabine—Haemoglobin—Irinotecan—colon cancer	0.000615	0.00257	CcSEcCtD
Fludarabine—Sinusitis—Fluorouracil—colon cancer	0.000612	0.00256	CcSEcCtD
Fludarabine—Haemorrhage—Irinotecan—colon cancer	0.000611	0.00256	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.00061	0.0112	CbGpPWpGaD
Fludarabine—Cardiac failure—Capecitabine—colon cancer	0.000606	0.00254	CcSEcCtD
Fludarabine—Cerebrovascular accident—Capecitabine—colon cancer	0.000604	0.00253	CcSEcCtD
Fludarabine—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.000592	0.00248	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—TYMS—colon cancer	0.000591	0.0108	CbGpPWpGaD
Fludarabine—Visual impairment—Irinotecan—colon cancer	0.000589	0.00247	CcSEcCtD
Fludarabine—Haemoglobin—Fluorouracil—colon cancer	0.000589	0.00247	CcSEcCtD
Fludarabine—RRM1—E2F transcription factor network—CDKN1A—colon cancer	0.000588	0.0108	CbGpPWpGaD
Fludarabine—Haemorrhage—Fluorouracil—colon cancer	0.000586	0.00245	CcSEcCtD
Fludarabine—Hypoaesthesia—Fluorouracil—colon cancer	0.000583	0.00244	CcSEcCtD
Fludarabine—Pharyngitis—Fluorouracil—colon cancer	0.000581	0.00244	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000569	0.0104	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—EP300—colon cancer	0.000559	0.0102	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000559	0.0102	CbGpPWpGaD
Fludarabine—Alopecia—Vincristine—colon cancer	0.000555	0.00232	CcSEcCtD
Fludarabine—Coma—Methotrexate—colon cancer	0.000554	0.00232	CcSEcCtD
Fludarabine—Dehydration—Capecitabine—colon cancer	0.00055	0.0023	CcSEcCtD
Fludarabine—Chills—Irinotecan—colon cancer	0.000549	0.0023	CcSEcCtD
Fludarabine—Arrhythmia—Irinotecan—colon cancer	0.000546	0.00229	CcSEcCtD
Fludarabine—Liver function test abnormal—Capecitabine—colon cancer	0.000546	0.00229	CcSEcCtD
Fludarabine—Alopecia—Irinotecan—colon cancer	0.00054	0.00226	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000539	0.00987	CbGpPWpGaD
Fludarabine—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000533	0.00223	CcSEcCtD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—CCND1—colon cancer	0.000528	0.00968	CbGpPWpGaD
Fludarabine—Arrhythmia—Fluorouracil—colon cancer	0.000523	0.00219	CcSEcCtD
Fludarabine—Alopecia—Fluorouracil—colon cancer	0.000517	0.00217	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000514	0.00941	CbGpPWpGaD
Fludarabine—Dysphagia—Capecitabine—colon cancer	0.000511	0.00214	CcSEcCtD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—CDKN1A—colon cancer	0.000511	0.00936	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CA7—colon cancer	0.000509	0.00932	CbGpPWpGaD
Fludarabine—Anaemia—Vincristine—colon cancer	0.000505	0.00212	CcSEcCtD
Fludarabine—Agitation—Vincristine—colon cancer	0.000502	0.0021	CcSEcCtD
Fludarabine—Sweating increased—Capecitabine—colon cancer	0.000498	0.00209	CcSEcCtD
Fludarabine—Angina pectoris—Capecitabine—colon cancer	0.000498	0.00209	CcSEcCtD
Fludarabine—Ill-defined disorder—Irinotecan—colon cancer	0.000494	0.00207	CcSEcCtD
Fludarabine—POLA1—G1/S Transition—TYMS—colon cancer	0.000493	0.00904	CbGpPWpGaD
Fludarabine—Anaemia—Irinotecan—colon cancer	0.000492	0.00206	CcSEcCtD
Fludarabine—Bronchitis—Capecitabine—colon cancer	0.000492	0.00206	CcSEcCtD
Fludarabine—Hepatic failure—Methotrexate—colon cancer	0.00049	0.00205	CcSEcCtD
Fludarabine—Leukopenia—Vincristine—colon cancer	0.000489	0.00205	CcSEcCtD
Fludarabine—RRM1—E2F transcription factor network—MYC—colon cancer	0.000487	0.00893	CbGpPWpGaD
Fludarabine—Pancytopenia—Capecitabine—colon cancer	0.000486	0.00203	CcSEcCtD
Fludarabine—Malaise—Irinotecan—colon cancer	0.00048	0.00201	CcSEcCtD
Fludarabine—Dysuria—Capecitabine—colon cancer	0.000478	0.002	CcSEcCtD
Fludarabine—Neutropenia—Capecitabine—colon cancer	0.000478	0.002	CcSEcCtD
Fludarabine—Leukopenia—Irinotecan—colon cancer	0.000476	0.002	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Capecitabine—colon cancer	0.000475	0.00199	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—MLH3—colon cancer	0.000475	0.0087	CbGpPWpGaD
Fludarabine—Convulsion—Vincristine—colon cancer	0.000474	0.00198	CcSEcCtD
Fludarabine—Anaemia—Fluorouracil—colon cancer	0.000471	0.00197	CcSEcCtD
Fludarabine—Myalgia—Vincristine—colon cancer	0.000465	0.00195	CcSEcCtD
Fludarabine—Visual disturbance—Methotrexate—colon cancer	0.000465	0.00195	CcSEcCtD
Fludarabine—Cough—Irinotecan—colon cancer	0.000464	0.00195	CcSEcCtD
Fludarabine—Hyperglycaemia—Capecitabine—colon cancer	0.000461	0.00193	CcSEcCtD
Fludarabine—Pneumonia—Capecitabine—colon cancer	0.000459	0.00192	CcSEcCtD
Fludarabine—Leukopenia—Fluorouracil—colon cancer	0.000456	0.00191	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000452	0.00189	CcSEcCtD
Fludarabine—Acute coronary syndrome—Capecitabine—colon cancer	0.000449	0.00188	CcSEcCtD
Fludarabine—Cerebrovascular accident—Methotrexate—colon cancer	0.000449	0.00188	CcSEcCtD
Fludarabine—Renal failure—Capecitabine—colon cancer	0.000448	0.00188	CcSEcCtD
Fludarabine—Discomfort—Irinotecan—colon cancer	0.000448	0.00188	CcSEcCtD
Fludarabine—Neuropathy peripheral—Capecitabine—colon cancer	0.000447	0.00187	CcSEcCtD
Fludarabine—Myocardial infarction—Capecitabine—colon cancer	0.000447	0.00187	CcSEcCtD
Fludarabine—Oedema—Vincristine—colon cancer	0.000446	0.00187	CcSEcCtD
Fludarabine—Anaphylactic shock—Vincristine—colon cancer	0.000446	0.00187	CcSEcCtD
Fludarabine—Stomatitis—Capecitabine—colon cancer	0.000444	0.00186	CcSEcCtD
Fludarabine—Infection—Vincristine—colon cancer	0.000443	0.00186	CcSEcCtD
Fludarabine—Urinary tract infection—Capecitabine—colon cancer	0.000443	0.00186	CcSEcCtD
Fludarabine—Convulsion—Fluorouracil—colon cancer	0.000442	0.00185	CcSEcCtD
Fludarabine—Confusional state—Irinotecan—colon cancer	0.000438	0.00184	CcSEcCtD
Fludarabine—Nervous system disorder—Vincristine—colon cancer	0.000437	0.00183	CcSEcCtD
Fludarabine—Thrombocytopenia—Vincristine—colon cancer	0.000437	0.00183	CcSEcCtD
Fludarabine—Haematuria—Capecitabine—colon cancer	0.000435	0.00182	CcSEcCtD
Fludarabine—Oedema—Irinotecan—colon cancer	0.000434	0.00182	CcSEcCtD
Fludarabine—Anaphylactic shock—Irinotecan—colon cancer	0.000434	0.00182	CcSEcCtD
Fludarabine—Myalgia—Fluorouracil—colon cancer	0.000434	0.00182	CcSEcCtD
Fludarabine—Infection—Irinotecan—colon cancer	0.000432	0.00181	CcSEcCtD
Fludarabine—Hyperhidrosis—Vincristine—colon cancer	0.000431	0.00181	CcSEcCtD
Fludarabine—Epistaxis—Capecitabine—colon cancer	0.00043	0.0018	CcSEcCtD
Fludarabine—Discomfort—Fluorouracil—colon cancer	0.000429	0.0018	CcSEcCtD
Fludarabine—Nervous system disorder—Irinotecan—colon cancer	0.000426	0.00178	CcSEcCtD
Fludarabine—Thrombocytopenia—Irinotecan—colon cancer	0.000425	0.00178	CcSEcCtD
Fludarabine—Anorexia—Vincristine—colon cancer	0.000425	0.00178	CcSEcCtD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—colon cancer	0.000424	0.00776	CbGpPWpGaD
Fludarabine—Hyperhidrosis—Irinotecan—colon cancer	0.00042	0.00176	CcSEcCtD
Fludarabine—Confusional state—Fluorouracil—colon cancer	0.00042	0.00176	CcSEcCtD
Fludarabine—Anaphylactic shock—Fluorouracil—colon cancer	0.000416	0.00174	CcSEcCtD
Fludarabine—Oedema—Fluorouracil—colon cancer	0.000416	0.00174	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—TYMS—colon cancer	0.000416	0.00762	CbGpPWpGaD
Fludarabine—Anorexia—Irinotecan—colon cancer	0.000414	0.00173	CcSEcCtD
Fludarabine—Infection—Fluorouracil—colon cancer	0.000413	0.00173	CcSEcCtD
Fludarabine—Haemoglobin—Capecitabine—colon cancer	0.000411	0.00172	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.000411	0.00753	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.00041	0.00752	CbGpPWpGaD
Fludarabine—Haemorrhage—Capecitabine—colon cancer	0.000409	0.00171	CcSEcCtD
Fludarabine—Nervous system disorder—Fluorouracil—colon cancer	0.000408	0.00171	CcSEcCtD
Fludarabine—Thrombocytopenia—Fluorouracil—colon cancer	0.000407	0.00171	CcSEcCtD
Fludarabine—Hypoaesthesia—Capecitabine—colon cancer	0.000407	0.00171	CcSEcCtD
Fludarabine—Liver function test abnormal—Methotrexate—colon cancer	0.000407	0.0017	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000406	0.0017	CcSEcCtD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—colon cancer	0.000406	0.00745	CbGpPWpGaD
Fludarabine—Pharyngitis—Capecitabine—colon cancer	0.000406	0.0017	CcSEcCtD
Fludarabine—RRM1—Metabolism—CHST5—colon cancer	0.000401	0.00734	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ODC1—colon cancer	0.000401	0.00734	CbGpPWpGaD
Fludarabine—Paraesthesia—Vincristine—colon cancer	0.000401	0.00168	CcSEcCtD
Fludarabine—Anorexia—Fluorouracil—colon cancer	0.000397	0.00166	CcSEcCtD
Fludarabine—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000397	0.00166	CcSEcCtD
Fludarabine—Visual impairment—Capecitabine—colon cancer	0.000394	0.00165	CcSEcCtD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—colon cancer	0.000393	0.0072	CbGpPWpGaD
Fludarabine—Paraesthesia—Irinotecan—colon cancer	0.00039	0.00163	CcSEcCtD
Fludarabine—Decreased appetite—Vincristine—colon cancer	0.000388	0.00162	CcSEcCtD
Fludarabine—Dyspnoea—Irinotecan—colon cancer	0.000387	0.00162	CcSEcCtD
Fludarabine—Erythema multiforme—Capecitabine—colon cancer	0.000387	0.00162	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Vincristine—colon cancer	0.000385	0.00161	CcSEcCtD
Fludarabine—Fatigue—Vincristine—colon cancer	0.000385	0.00161	CcSEcCtD
Fludarabine—Dyspepsia—Irinotecan—colon cancer	0.000382	0.0016	CcSEcCtD
Fludarabine—Pain—Vincristine—colon cancer	0.000381	0.0016	CcSEcCtD
Fludarabine—Constipation—Vincristine—colon cancer	0.000381	0.0016	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000379	0.00159	CcSEcCtD
Fludarabine—Decreased appetite—Irinotecan—colon cancer	0.000378	0.00158	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Irinotecan—colon cancer	0.000375	0.00157	CcSEcCtD
Fludarabine—Fatigue—Irinotecan—colon cancer	0.000375	0.00157	CcSEcCtD
Fludarabine—Paraesthesia—Fluorouracil—colon cancer	0.000374	0.00157	CcSEcCtD
Fludarabine—Pain—Irinotecan—colon cancer	0.000371	0.00156	CcSEcCtD
Fludarabine—Constipation—Irinotecan—colon cancer	0.000371	0.00156	CcSEcCtD
Fludarabine—Dyspnoea—Fluorouracil—colon cancer	0.000371	0.00155	CcSEcCtD
Fludarabine—Chills—Capecitabine—colon cancer	0.000367	0.00154	CcSEcCtD
Fludarabine—Dyspepsia—Fluorouracil—colon cancer	0.000366	0.00153	CcSEcCtD
Fludarabine—Arrhythmia—Capecitabine—colon cancer	0.000366	0.00153	CcSEcCtD
Fludarabine—Decreased appetite—Fluorouracil—colon cancer	0.000362	0.00152	CcSEcCtD
Fludarabine—Alopecia—Capecitabine—colon cancer	0.000362	0.00152	CcSEcCtD
Fludarabine—Pancytopenia—Methotrexate—colon cancer	0.000361	0.00151	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000359	0.0015	CcSEcCtD
Fludarabine—Feeling abnormal—Irinotecan—colon cancer	0.000358	0.0015	CcSEcCtD
Fludarabine—Malnutrition—Capecitabine—colon cancer	0.000356	0.00149	CcSEcCtD
Fludarabine—Neutropenia—Methotrexate—colon cancer	0.000356	0.00149	CcSEcCtD
Fludarabine—Dysuria—Methotrexate—colon cancer	0.000356	0.00149	CcSEcCtD
Fludarabine—Pain—Fluorouracil—colon cancer	0.000356	0.00149	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Methotrexate—colon cancer	0.000354	0.00148	CcSEcCtD
Fludarabine—Body temperature increased—Vincristine—colon cancer	0.000353	0.00148	CcSEcCtD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—colon cancer	0.000348	0.00637	CbGpPWpGaD
Fludarabine—Body temperature increased—Irinotecan—colon cancer	0.000343	0.00144	CcSEcCtD
Fludarabine—Feeling abnormal—Fluorouracil—colon cancer	0.000343	0.00144	CcSEcCtD
Fludarabine—Pneumonia—Methotrexate—colon cancer	0.000341	0.00143	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000336	0.00141	CcSEcCtD
Fludarabine—Renal failure—Methotrexate—colon cancer	0.000334	0.0014	CcSEcCtD
Fludarabine—POLA1—E2F transcription factor network—CDKN1A—colon cancer	0.000331	0.00607	CbGpPWpGaD
Fludarabine—Stomatitis—Methotrexate—colon cancer	0.000331	0.00139	CcSEcCtD
Fludarabine—Ill-defined disorder—Capecitabine—colon cancer	0.000331	0.00138	CcSEcCtD
Fludarabine—Anaemia—Capecitabine—colon cancer	0.000329	0.00138	CcSEcCtD
Fludarabine—Body temperature increased—Fluorouracil—colon cancer	0.000329	0.00138	CcSEcCtD
Fludarabine—Hypersensitivity—Vincristine—colon cancer	0.000329	0.00138	CcSEcCtD
Fludarabine—Adenosine triphosphate—ABCB1—colon cancer	0.000327	0.0808	CrCbGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—colon cancer	0.000326	0.00597	CbGpPWpGaD
Fludarabine—Haematuria—Methotrexate—colon cancer	0.000324	0.00136	CcSEcCtD
Fludarabine—Malaise—Capecitabine—colon cancer	0.000321	0.00135	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000321	0.00588	CbGpPWpGaD
Fludarabine—Epistaxis—Methotrexate—colon cancer	0.00032	0.00134	CcSEcCtD
Fludarabine—Hypersensitivity—Irinotecan—colon cancer	0.00032	0.00134	CcSEcCtD
Fludarabine—Asthenia—Vincristine—colon cancer	0.00032	0.00134	CcSEcCtD
Fludarabine—Leukopenia—Capecitabine—colon cancer	0.000319	0.00134	CcSEcCtD
Fludarabine—POLA1—E2F transcription factor network—EP300—colon cancer	0.000315	0.00577	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000315	0.00577	CbGpPWpGaD
Fludarabine—Asthenia—Irinotecan—colon cancer	0.000312	0.00131	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000312	0.00571	CbGpPWpGaD
Fludarabine—Cough—Capecitabine—colon cancer	0.000311	0.0013	CcSEcCtD
Fludarabine—DCK—Metabolism—ODC1—colon cancer	0.000308	0.00565	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CHST5—colon cancer	0.000308	0.00565	CbGpPWpGaD
Fludarabine—Hypersensitivity—Fluorouracil—colon cancer	0.000307	0.00128	CcSEcCtD
Fludarabine—Haemoglobin—Methotrexate—colon cancer	0.000306	0.00128	CcSEcCtD
Fludarabine—Diarrhoea—Vincristine—colon cancer	0.000305	0.00128	CcSEcCtD
Fludarabine—Haemorrhage—Methotrexate—colon cancer	0.000305	0.00128	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000303	0.00556	CbGpPWpGaD
Fludarabine—Arthralgia—Capecitabine—colon cancer	0.000303	0.00127	CcSEcCtD
Fludarabine—Myalgia—Capecitabine—colon cancer	0.000303	0.00127	CcSEcCtD
Fludarabine—Pharyngitis—Methotrexate—colon cancer	0.000302	0.00127	CcSEcCtD
Fludarabine—Discomfort—Capecitabine—colon cancer	0.0003	0.00126	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—colon cancer	0.000297	0.00545	CbGpPWpGaD
Fludarabine—Diarrhoea—Irinotecan—colon cancer	0.000297	0.00125	CcSEcCtD
Fludarabine—Pruritus—Fluorouracil—colon cancer	0.000294	0.00123	CcSEcCtD
Fludarabine—Visual impairment—Methotrexate—colon cancer	0.000294	0.00123	CcSEcCtD
Fludarabine—Confusional state—Capecitabine—colon cancer	0.000293	0.00123	CcSEcCtD
Fludarabine—Oedema—Capecitabine—colon cancer	0.000291	0.00122	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000289	0.0053	CbGpPWpGaD
Fludarabine—Infection—Capecitabine—colon cancer	0.000289	0.00121	CcSEcCtD
Fludarabine—Erythema multiforme—Methotrexate—colon cancer	0.000288	0.00121	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—colon cancer	0.000288	0.00527	CbGpPWpGaD
Fludarabine—Nervous system disorder—Capecitabine—colon cancer	0.000285	0.00119	CcSEcCtD
Fludarabine—Diarrhoea—Fluorouracil—colon cancer	0.000285	0.00119	CcSEcCtD
Fludarabine—Thrombocytopenia—Capecitabine—colon cancer	0.000285	0.00119	CcSEcCtD
Fludarabine—Vomiting—Vincristine—colon cancer	0.000284	0.00119	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000281	0.00516	CbGpPWpGaD
Fludarabine—Rash—Vincristine—colon cancer	0.000281	0.00118	CcSEcCtD
Fludarabine—Hyperhidrosis—Capecitabine—colon cancer	0.000281	0.00118	CcSEcCtD
Fludarabine—Dermatitis—Vincristine—colon cancer	0.000281	0.00118	CcSEcCtD
Fludarabine—Headache—Vincristine—colon cancer	0.000279	0.00117	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000279	0.00511	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000277	0.00508	CbGpPWpGaD
Fludarabine—Anorexia—Capecitabine—colon cancer	0.000277	0.00116	CcSEcCtD
Fludarabine—Vomiting—Irinotecan—colon cancer	0.000276	0.00116	CcSEcCtD
Fludarabine—POLA1—E2F transcription factor network—MYC—colon cancer	0.000275	0.00503	CbGpPWpGaD
Fludarabine—Rash—Irinotecan—colon cancer	0.000274	0.00115	CcSEcCtD
Fludarabine—Dermatitis—Irinotecan—colon cancer	0.000274	0.00115	CcSEcCtD
Fludarabine—Chills—Methotrexate—colon cancer	0.000273	0.00115	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000272	0.00499	CbGpPWpGaD
Fludarabine—Headache—Irinotecan—colon cancer	0.000272	0.00114	CcSEcCtD
Fludarabine—Alopecia—Methotrexate—colon cancer	0.000269	0.00113	CcSEcCtD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—colon cancer	0.000268	0.00491	CbGpPWpGaD
Fludarabine—POLA1—Synthesis of DNA—CDKN1A—colon cancer	0.000266	0.00487	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—BUB1B—colon cancer	0.000266	0.00487	CbGpPWpGaD
Fludarabine—Malnutrition—Methotrexate—colon cancer	0.000265	0.00111	CcSEcCtD
Fludarabine—Nausea—Vincristine—colon cancer	0.000265	0.00111	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000265	0.00111	CcSEcCtD
Fludarabine—Vomiting—Fluorouracil—colon cancer	0.000265	0.00111	CcSEcCtD
Fludarabine—Rash—Fluorouracil—colon cancer	0.000262	0.0011	CcSEcCtD
Fludarabine—Dermatitis—Fluorouracil—colon cancer	0.000262	0.0011	CcSEcCtD
Fludarabine—Paraesthesia—Capecitabine—colon cancer	0.000261	0.00109	CcSEcCtD
Fludarabine—Headache—Fluorouracil—colon cancer	0.000261	0.00109	CcSEcCtD
Fludarabine—Dyspnoea—Capecitabine—colon cancer	0.000259	0.00109	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000259	0.00475	CbGpPWpGaD
Fludarabine—Nausea—Irinotecan—colon cancer	0.000258	0.00108	CcSEcCtD
Fludarabine—Dyspepsia—Capecitabine—colon cancer	0.000256	0.00107	CcSEcCtD
Fludarabine—Decreased appetite—Capecitabine—colon cancer	0.000253	0.00106	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000252	0.00462	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000251	0.00105	CcSEcCtD
Fludarabine—Fatigue—Capecitabine—colon cancer	0.000251	0.00105	CcSEcCtD
Fludarabine—POLA1—DNA Replication—CDKN1A—colon cancer	0.000249	0.00457	CbGpPWpGaD
Fludarabine—Constipation—Capecitabine—colon cancer	0.000249	0.00104	CcSEcCtD
Fludarabine—Pain—Capecitabine—colon cancer	0.000249	0.00104	CcSEcCtD
Fludarabine—Nausea—Fluorouracil—colon cancer	0.000247	0.00104	CcSEcCtD
Fludarabine—Ill-defined disorder—Methotrexate—colon cancer	0.000246	0.00103	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000245	0.0045	CbGpPWpGaD
Fludarabine—Anaemia—Methotrexate—colon cancer	0.000245	0.00103	CcSEcCtD
Fludarabine—POLA1—G1/S Transition—CDKN1A—colon cancer	0.00024	0.0044	CbGpPWpGaD
Fludarabine—Feeling abnormal—Capecitabine—colon cancer	0.00024	0.001	CcSEcCtD
Fludarabine—Malaise—Methotrexate—colon cancer	0.000239	0.001	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—colon cancer	0.000239	0.00437	CbGpPWpGaD
Fludarabine—Leukopenia—Methotrexate—colon cancer	0.000237	0.000995	CcSEcCtD
Fludarabine—Cough—Methotrexate—colon cancer	0.000231	0.00097	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000231	0.00424	CbGpPWpGaD
Fludarabine—Body temperature increased—Capecitabine—colon cancer	0.00023	0.000963	CcSEcCtD
Fludarabine—Convulsion—Methotrexate—colon cancer	0.00023	0.000963	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000226	0.00414	CbGpPWpGaD
Fludarabine—Arthralgia—Methotrexate—colon cancer	0.000226	0.000946	CcSEcCtD
Fludarabine—Myalgia—Methotrexate—colon cancer	0.000226	0.000946	CcSEcCtD
Fludarabine—POLA1—S Phase—CCND1—colon cancer	0.000225	0.00413	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000225	0.00413	CbGpPWpGaD
Fludarabine—Discomfort—Methotrexate—colon cancer	0.000223	0.000935	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000221	0.00405	CbGpPWpGaD
Fludarabine—Confusional state—Methotrexate—colon cancer	0.000218	0.000914	CcSEcCtD
Fludarabine—POLA1—S Phase—CDKN1A—colon cancer	0.000218	0.004	CbGpPWpGaD
Fludarabine—Anaphylactic shock—Methotrexate—colon cancer	0.000216	0.000907	CcSEcCtD
Fludarabine—Infection—Methotrexate—colon cancer	0.000215	0.000901	CcSEcCtD
Fludarabine—Hypersensitivity—Capecitabine—colon cancer	0.000214	0.000897	CcSEcCtD
Fludarabine—Nervous system disorder—Methotrexate—colon cancer	0.000212	0.000889	CcSEcCtD
Fludarabine—Thrombocytopenia—Methotrexate—colon cancer	0.000212	0.000888	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CCND1—colon cancer	0.000209	0.00384	CbGpPWpGaD
Fludarabine—Hyperhidrosis—Methotrexate—colon cancer	0.000209	0.000877	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—MLH1—colon cancer	0.000209	0.00383	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000209	0.00382	CbGpPWpGaD
Fludarabine—Asthenia—Capecitabine—colon cancer	0.000209	0.000874	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000207	0.00379	CbGpPWpGaD
Fludarabine—Anorexia—Methotrexate—colon cancer	0.000206	0.000864	CcSEcCtD
Fludarabine—Pruritus—Capecitabine—colon cancer	0.000206	0.000862	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—colon cancer	0.000202	0.00371	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—MYC—colon cancer	0.000199	0.00365	CbGpPWpGaD
Fludarabine—Diarrhoea—Capecitabine—colon cancer	0.000199	0.000833	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—BUB1B—colon cancer	0.000199	0.00364	CbGpPWpGaD
Fludarabine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000197	0.000826	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—colon cancer	0.000196	0.00359	CbGpPWpGaD
Fludarabine—Paraesthesia—Methotrexate—colon cancer	0.000194	0.000814	CcSEcCtD
Fludarabine—Dyspnoea—Methotrexate—colon cancer	0.000193	0.000808	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000192	0.00351	CbGpPWpGaD
Fludarabine—Dyspepsia—Methotrexate—colon cancer	0.000191	0.000798	CcSEcCtD
Fludarabine—Decreased appetite—Methotrexate—colon cancer	0.000188	0.000788	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000187	0.000783	CcSEcCtD
Fludarabine—Fatigue—Methotrexate—colon cancer	0.000187	0.000782	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000185	0.0034	CbGpPWpGaD
Fludarabine—Pain—Methotrexate—colon cancer	0.000185	0.000775	CcSEcCtD
Fludarabine—Vomiting—Capecitabine—colon cancer	0.000185	0.000774	CcSEcCtD
Fludarabine—Rash—Capecitabine—colon cancer	0.000183	0.000768	CcSEcCtD
Fludarabine—Dermatitis—Capecitabine—colon cancer	0.000183	0.000767	CcSEcCtD
Fludarabine—Headache—Capecitabine—colon cancer	0.000182	0.000763	CcSEcCtD
Fludarabine—POLA1—S Phase—MYC—colon cancer	0.000181	0.00331	CbGpPWpGaD
Fludarabine—Feeling abnormal—Methotrexate—colon cancer	0.000178	0.000747	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—BUB1B—colon cancer	0.000178	0.00326	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000175	0.00322	CbGpPWpGaD
Fludarabine—Nausea—Capecitabine—colon cancer	0.000173	0.000724	CcSEcCtD
Fludarabine—Body temperature increased—Methotrexate—colon cancer	0.000171	0.000717	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—MYC—colon cancer	0.000168	0.00308	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000163	0.00299	CbGpPWpGaD
Fludarabine—Hypersensitivity—Methotrexate—colon cancer	0.000159	0.000668	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000159	0.00291	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000157	0.00288	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000157	0.00287	CbGpPWpGaD
Fludarabine—Asthenia—Methotrexate—colon cancer	0.000155	0.000651	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000153	0.00281	CbGpPWpGaD
Fludarabine—Pruritus—Methotrexate—colon cancer	0.000153	0.000642	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—TYMS—colon cancer	0.000152	0.00279	CbGpPWpGaD
Fludarabine—Diarrhoea—Methotrexate—colon cancer	0.000148	0.00062	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000146	0.00267	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000142	0.0026	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000138	0.00253	CbGpPWpGaD
Fludarabine—Vomiting—Methotrexate—colon cancer	0.000138	0.000577	CcSEcCtD
Fludarabine—Rash—Methotrexate—colon cancer	0.000136	0.000572	CcSEcCtD
Fludarabine—Dermatitis—Methotrexate—colon cancer	0.000136	0.000571	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—TYMS—colon cancer	0.000136	0.0025	CbGpPWpGaD
Fludarabine—Headache—Methotrexate—colon cancer	0.000136	0.000568	CcSEcCtD
Fludarabine—Nausea—Methotrexate—colon cancer	0.000129	0.000539	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000127	0.00233	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000127	0.00232	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000124	0.00228	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000118	0.00215	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000108	0.00198	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ABCB1—colon cancer	0.000106	0.00194	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000104	0.00191	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—TYMS—colon cancer	0.000104	0.00191	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	8.82e-05	0.00162	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ABCB1—colon cancer	8.15e-05	0.00149	CbGpPWpGaD
Fludarabine—DCK—Metabolism—TYMS—colon cancer	8e-05	0.00147	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CCND1—colon cancer	7.68e-05	0.00141	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—colon cancer	7.43e-05	0.00136	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PPARG—colon cancer	7.37e-05	0.00135	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—EP300—colon cancer	7.07e-05	0.00129	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CCND1—colon cancer	6.86e-05	0.00126	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN1A—colon cancer	6.64e-05	0.00122	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—EP300—colon cancer	6.32e-05	0.00116	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MYC—colon cancer	6.16e-05	0.00113	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PTGS2—colon cancer	5.79e-05	0.00106	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PPARG—colon cancer	5.67e-05	0.00104	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MYC—colon cancer	5.5e-05	0.00101	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—EP300—colon cancer	4.82e-05	0.000883	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—TP53—colon cancer	4.52e-05	0.000828	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PTGS2—colon cancer	4.46e-05	0.000817	CbGpPWpGaD
Fludarabine—DCK—Metabolism—EP300—colon cancer	3.71e-05	0.00068	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CA—colon cancer	3.56e-05	0.000653	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—AKT1—colon cancer	2.91e-05	0.000534	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CA—colon cancer	2.74e-05	0.000503	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AKT1—colon cancer	2.24e-05	0.000411	CbGpPWpGaD
